Medical Weight Loss for New Haven, Connecticut Residents

New Haven, Connecticut residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving New Haven through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Connecticut: there is no local New Haven office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why New Haven Residents Choose New Hope Weight Loss

We are built for people who would rather not deal with insurance at all. New Hope is cash-pay friendly, so there are no prior authorizations, no denials, and no waiting on a carrier to decide what you are allowed to try. Patients in New Haven pay a flat physician fee of $119 and a clear monthly medication price, and we accept HSA, FSA, Klarna, and Affirm so the cost can fit your budget without a fight.

Medical weight loss for New Haven is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

From the first visit to your refills, people in New Haven, Connecticut are cared for by Dr. Sharma through telehealth, so the only thing missing is the commute to Costa Mesa. We care for patients throughout Downtown, East Rock, Westville, and the greater south-central Connecticut area. From your first question to your ongoing refills, the whole Connecticut experience is built to feel personal, private, and genuinely supported.

There is no separate "out of town" rate, so New Haven and Connecticut patients get the same program at the same price as everyone Dr. Sharma sees. For patients across New Haven, compounded semaglutide starts at $166 per month, with a 90-day program available for $499, and the medication cost is kept separate from the $119 physician review. New Hope Weight Loss serves patients throughout Connecticut by secure telehealth from our Costa Mesa, California clinic, bringing physician-supervised GLP-1 programs to your door without an office visit.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in New Haven and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for New Haven

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across New Haven and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your New Haven door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, New Haven

I am searching for weight loss care near New Haven. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in New Haven, Connecticut connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in New Haven?

Not at all. The telehealth format covers New Haven patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to New Haven in cold-pack packaging built to keep it cool and stable.

What are the program costs for New Haven patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and New Haven patients face no distance surcharge.

What areas of New Haven do you serve?

We serve patients from across New Haven by telehealth, including Downtown, East Rock, Westville, and the greater south-central Connecticut area.

What does treatment cost for New Haven patients?

The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for New Haven.

New Haven Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving New Haven, Connecticut by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.